Key PointsPfizer shares have underperformed since 2021, with the recent poor performance reflecting concerns about impending patent expirations.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。

Key PointsPfizer shares have underperformed since 2021, with the recent poor performance reflecting concerns about impending patent expirations.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。